INTELLIA THERAPEUTICS INC (NTLA) Institutional Shareholders
INTELLIA THERAPEUTICS INC (NTLA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.43B in NTLA holdings during the latest filing period.
ARK Invest is currently the largest disclosed institutional shareholder of NTLA tracked by InsiderSet, reporting ownership valued at approximately $186.01M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $154.96M, representing an estimated loss of -16.69% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 59% of the total disclosed NTLA value among the investors covered in this analysis. Major shareholders include ARK Invest, Blackrock, Inc., State Street Corp, and several other long-term asset managers with concentrated positions in INTELLIA THERAPEUTICS INC (NTLA).
This page ranks the largest institutional NTLA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
304
Total Reported Value
$1.43B
Largest Holder
ARK Invest
Largest Position
$186.01M
Insider Transactions (90d)
10
Latest Filing Quarter
Q2 2026
New Institutional Positions
69
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| ARK Invest | Cathie Wood | 1.45% | 14,509,247 | $186,008,545 | $154,958,758 | -$31,049,787 | -16.69% |
| Blackrock, Inc. | 0.00% | 12,155,806 | $155,837,437 | $129,824,008 | -$26,013,429 | -16.69% | |
| State Street Corp | 0.00% | 6,922,676 | $88,748,706 | $73,934,180 | -$14,814,526 | -16.69% | |
| Vanguard Portfolio Management Llc | 0.00% | 6,223,325 | $79,783,027 | $66,465,111 | -$13,317,916 | -16.69% | |
| D. E. Shaw & Co., Inc. | 0.06% | 5,728,177 | $73,435,230 | $61,176,930 | -$12,258,300 | -16.69% | |
| Vanguard Capital Management Llc | 0.00% | 5,084,105 | $65,178,226 | $54,298,241 | -$10,879,985 | -16.69% | |
| Two Sigma Investments, Lp | 0.05% | 4,705,901 | $60,329,651 | $50,259,023 | -$10,070,628 | -16.69% | |
| Sumitomo Mitsui Trust Group, Inc. | 0.03% | 2,897,529 | $49,026,191 | $30,945,610 | -$18,080,581 | -36.88% | |
| Regeneron Pharmaceuticals, Inc. | 99.14% | 3,702,995 | $47,472,396 | $39,547,987 | -$7,924,409 | -16.69% | |
| Geode Capital Management, Llc | 0.00% | 2,851,472 | $36,563,024 | $30,453,721 | -$6,109,303 | -16.71% | |
| Ubs Group Ag | 0.01% | 2,689,486 | $34,479,209 | $28,723,710 | -$5,755,499 | -16.69% | |
| Dimensional Fund Advisors Lp | 0.01% | 2,318,110 | $29,708,722 | $24,757,415 | -$4,951,307 | -16.67% | |
| Morgan Stanley | 0.00% | 2,081,397 | $26,683,520 | $22,229,320 | -$4,454,200 | -16.69% | |
| Fmr Llc | 0.00% | 2,067,222 | $26,501,787 | $22,077,931 | -$4,423,856 | -16.69% | |
| Amova Asset Management Americas, Inc. | 0.36% | 1,973,061 | $25,274,911 | $21,072,291 | -$4,202,620 | -16.63% | |
| Contrarius Group Holdings Ltd | 1.39% | 1,911,839 | $24,509,776 | $20,418,441 | -$4,091,335 | -16.69% | |
| Jupiter Asset Management Ltd | 0.12% | 1,781,063 | $22,833,228 | $19,021,753 | -$3,811,475 | -16.69% | |
| Goldman Sachs Group Inc | 0.00% | 1,628,241 | $20,874,050 | $17,389,614 | -$3,484,436 | -16.69% | |
| Voloridge Investment Management, Llc | 0.08% | 1,611,534 | $20,659,866 | $17,211,183 | -$3,448,683 | -16.69% | |
| Arrowstreet Capital, Limited Partnership | 0.01% | 1,397,243 | $17,912,655 | $14,922,555 | -$2,990,100 | -16.69% | |
| Bank Of America Corp | 0.00% | 1,381,703 | $17,713,432 | $14,756,588 | -$2,956,844 | -16.69% | |
| Iq Eq Fund Management (Ireland) Ltd | 0.84% | 777,948 | $13,162,880 | $8,308,485 | -$4,854,395 | -36.88% | |
| Stifel Financial Corp | 0.01% | 1,012,706 | $12,982,921 | $10,815,700 | -$2,167,221 | -16.69% | |
| Northern Trust Corp | 0.00% | 966,293 | $12,387,876 | $10,320,009 | -$2,067,867 | -16.69% | |
| Charles Schwab Investment Management Inc | 0.00% | 941,285 | $12,067,274 | $10,052,924 | -$2,014,350 | -16.69% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.02% | 748,636 | $9,597,514 | $7,995,432 | -$1,602,082 | -16.69% | |
| Vanguard Fiduciary Trust Co | 0.00% | 748,103 | $9,590,680 | $7,989,740 | -$1,600,940 | -16.69% | |
| Capital Fund Management S.A. | 0.08% | 730,122 | $9,360,164 | $7,797,703 | -$1,562,461 | -16.69% | |
| Aqr Capital Management Llc | 0.00% | 630,529 | $8,083,382 | $6,734,050 | -$1,349,332 | -16.69% | |
| Marex Group Plc | 0.09% | 623,600 | $7,994,552 | $6,660,048 | -$1,334,504 | -16.69% | |
| Bnp Paribas Financial Markets | 0.00% | 579,430 | $7,428,293 | $6,188,312 | -$1,239,981 | -16.69% | |
| Raymond James Financial Inc | 0.00% | 576,930 | $7,396,243 | $6,161,612 | -$1,234,631 | -16.69% | |
| Vestmark Advisory Solutions, Inc. | 0.08% | 550,144 | $7,052,846 | $5,875,538 | -$1,177,308 | -16.69% | |
| Susquehanna International Group, Llp | 0.01% | 521,465 | $6,685,181 | $5,569,246 | -$1,115,935 | -16.69% | |
| Royal Bank Of Canada | 0.00% | 465,499 | $5,968,000 | $4,971,529 | -$996,471 | -16.70% | |
| Citadel Advisors Llc | 0.00% | 458,241 | $5,874,650 | $4,894,014 | -$980,636 | -16.69% | |
| Pinnacle Associates Ltd | 0.06% | 339,024 | $5,736,286 | $3,620,776 | -$2,115,510 | -36.88% | |
| Birchview Capital, Lp | 3.25% | 445,400 | $5,710,028 | $4,756,872 | -$953,156 | -16.69% | |
| Invesco Ltd. | 0.00% | 434,753 | $5,573,533 | $4,643,162 | -$930,371 | -16.69% | |
| Himension Capital (Singapore) Pte. Ltd. | 0.42% | 429,540 | $5,506,703 | $4,587,487 | -$919,216 | -16.69% | |
| Jane Street Group, Llc | 0.01% | 384,957 | $4,935,148 | $4,111,341 | -$823,807 | -16.69% | |
| Federated Hermes, Inc. | 0.01% | 368,617 | $4,725,670 | $3,936,830 | -$788,840 | -16.69% | |
| Casdin Capital, Llc | 0.34% | 355,000 | $4,551,100 | $3,791,400 | -$759,700 | -16.69% | |
| Armistice Capital, Llc | 0.14% | 336,000 | $4,307,520 | $3,588,480 | -$719,040 | -16.69% | |
| Wells Fargo & Company/Mn | 0.00% | 333,897 | $4,280,563 | $3,566,020 | -$714,543 | -16.69% | |
| Bank Of New York Mellon Corp | 0.00% | 328,000 | $4,204,965 | $3,503,040 | -$701,925 | -16.69% | |
| Citigroup Inc | 0.00% | 233,257 | $3,946,708 | $2,491,185 | -$1,455,523 | -36.88% | |
| Hennion & Walsh Asset Management, Inc. | 0.11% | 220,523 | $3,731,249 | $2,355,186 | -$1,376,063 | -36.88% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 283,958 | $3,640,342 | $3,032,671 | -$607,671 | -16.69% | |
| Point72 Asset Management, L.P. | 0.01% | 270,011 | $3,461,541 | $2,883,717 | -$577,824 | -16.69% |
Frequently asked questions about NTLA
Who owns the most NTLA stock?
The largest holders of NTLA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INTELLIA THERAPEUTICS INC (NTLA).
Is NTLA widely held by superinvestors?
Many widely followed stocks like NTLA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NTLA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.